Gexval
Fujisawa
About Gexval
GEXVal is a research and development-oriented drug discovery company. The company specializes in the creation of treatments for rare and incurable diseases. The mission of GEXVal is to provide patients and families with the rare and incurable diseases with innovative, cost-effective treatment options that will enhance their health and quality of life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Jan 2025)
- Website: gexval.com
Industries & Categories
Emergency Medicine, Health Care, Medical
Canonical: https://fsome.com/organization/gexval-92630 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.